Clinical trials
Phase 1 Carcinoid Tumor trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Withdrawn | 3 |
| Terminated | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 2 |
| M.D. Anderson Cancer Center | 2 |
| Novartis Pharmaceuticals | 2 |
| Lale Kostakoglu | 1 |
| Massachusetts General Hospital | 1 |
| Molecular Insight Pharmaceuticals, Inc. | 1 |
| Neotropix | 1 |
| Provectus Biopharmaceuticals, Inc. | 1 |
| RayzeBio, Inc. | 1 |
| University of Alabama at Birmingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoid Tumor | 15 |
| Neuroendocrine Tumors | 7 |
| Adenoma, Islet Cell | 3 |
| Lung Neoplasms | 2 |
| Melanoma | 2 |
| Pheochromocytoma | 2 |
| Small Cell Lung Carcinoma | 2 |
| Acromegaly | 1 |
| Adrenal Cortex Neoplasms | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.